InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Leach Jacob Steven, Chief Technology Officer. Director active across 2 companies, notably DEXCOM INC. Aggregated, 11 disclosures have been recorded. Total volume traded: €25.7m. The latest transaction was filed on 8 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
€66,741 shares@ €0.00090.0000% mcap0.0% of flow
Common Stock
SEC:0001093557-22-000049:0·
€32,925 shares@ €0.00090.0000% mcap0.0% of flow
Common Stock
SEC:0001093557-21-000292·
€32,925 shares@ €0.00090.0000% mcap0.0% of flow
Common Stock
SEC:0001093557-21-000292:0·
€571,3021,248 shares@ €457.7740.0022% mcap4.5% of flow
Common Stock
SEC:0001093557-21-000214·
€571,3021,248 shares@ €457.7740.0022% mcap2.2% of flow
Common Stock
SEC:0001093557-21-000214:0·
€65,26850,000 shares@ €1.3054100.0% of flow
Common Stock
SEC:0001225208-21-011565·
Ideal exit: 13 May 2022 (T+270)
€65,26850,000 shares@ €1.30540.58% mcap50.0% of flow
Common Stock
SEC:0001225208-21-011565:0·
Ideal exit: 13 May 2022 (T+270)
€5m12,087 shares@ €400.82410.019% mcap37.9% of flow
Common Stock
SEC:0001093557-21-000193·
€5m12,087 shares@ €400.82410.019% mcap18.9% of flow
Common Stock
SEC:0001093557-21-000193:0·
€7m22,755 shares@ €324.24880.029% mcap57.7% of flow
Common Stock
SEC:0001093557-21-000167·
€7m22,755 shares@ €324.24880.029% mcap28.8% of flow
Common Stock
SEC:0001093557-21-000167:0·
11 of 11 declarations
About Leach Jacob Steven
Jacob Steven Leach is the EVP Chief Technology Officer and Director at Dexcom Inc and SenesTech, Inc. He is responsible for technology strategy and innovation within these companies. His role is essential in guiding strategic decisions and ensuring technological performance.
